BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

New Teva Pharmaceutical Industries Limited (TEVA) CEO Ditches Proteologics, Ltd. Collaboration


12/27/2012 7:52:56 AM

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today notified Proteologics Ltd. (TASE: PRTL) that it was terminating the licensing agreement to develop several molecules on which the two companies were collaborating. Proteologics will have the right to continue development and commercialization of the molecules as part of its research plans independently. Proteologics is a drug development company which focuses primarily on discovering inhibitors for specific E3 ubiquitin ligases for targeted therapies for cancer and inflammatory diseases. The termination is part of Teva's new strategic plan. Proteologics CEO Joshua Levine said, "We thank Teva for its early-stage investment in Proteologics, and for its contribution over the years to the development and progress of our innovative molecules for the treatment of cancer and inflammatory diseases.

Read at Globes Online

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES